,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2019-06-28 03:00:00,Following the smart money on Wall Street can help you find great investment ideas.,0.44830575585365295,0.012076816521584988,0.5396173596382141,neutral,0.4362289309501648
1,2019-06-28 03:00:00,"But you have to take the ideas with a grain of salt, because some big-name investors may be willing to take on more risk than you should be shouldering.",0.25416722893714905,0.021194489672780037,0.7246382236480713,neutral,0.23297274112701416
2,2019-06-28 03:00:00,"To that end, some very big investors have been buying shares of software-as-a-service leader Salesforce.com (NYSE: CRM) and precious metals streamer Royal Gold (NASDAQ: RGLD), two names worth a close look today.",0.6186053156852722,0.02252718061208725,0.3588675260543823,positive,0.5960781574249268
3,2019-06-28 03:00:00,"However, those jumping into biotech start-up Harpoon Therapeutics (NASDAQ: HARP) may be early to the party.",0.06687518954277039,0.022364960983395576,0.9107598066329956,neutral,0.04451023042201996
4,2019-06-28 03:00:00,Here's what you need to know about this trio of smart-money favorites.,0.03940049558877945,0.009949837811291218,0.9506496787071228,neutral,0.029450658708810806
5,2019-06-28 03:00:00,Brian Stoffel (Salesforce): Ken Fisher has a brilliant track record as a money manager.,0.6979029178619385,0.01476312056183815,0.2873339354991913,positive,0.6831398010253906
6,2019-06-28 03:00:00,"Today, his fund has more than $94 billion in assets under management.",0.0853542611002922,0.005524664185941219,0.909121036529541,neutral,0.07982959598302841
7,2019-06-28 03:00:00,"During the first quarter of 2019, he made a substantial increase to one of his positions -- buying almost 2 million shares of Salesforce.",0.9107820987701416,0.013916557654738426,0.07530143111944199,positive,0.8968655467033386
8,2019-06-28 03:00:00,It currently stands as the 25th-largest position his fund owns (note: the fund owns well over 750 stocks).,0.1694846749305725,0.006929988041520119,0.8235853314399719,neutral,0.16255468130111694
9,2019-06-28 03:00:00,It might seem like Fisher is late to the game on Salesforce.,0.06380924582481384,0.6220203042030334,0.3141704201698303,negative,-0.558211088180542
10,2019-06-28 03:00:00,"After all, shares have advanced 1,500% over the past decade.",0.9444673657417297,0.01651167869567871,0.03902091085910797,positive,0.927955687046051
11,2019-06-28 03:00:00,But the company -- which was the first major player in the economy to capitalize on the software-as-a-service (SaaS) business model -- continues to show robust growth.,0.9450069069862366,0.014570538885891438,0.04042258858680725,positive,0.930436372756958
12,2019-06-28 03:00:00,It has continually shown that it can grow sales at a clip above 20% per year -- no small feat for a $120 billion company.,0.9334947466850281,0.01541930716484785,0.051085878163576126,positive,0.918075442314148
13,2019-06-28 03:00:00,So does that make Salesforce a good stock for you?,0.20295612514019012,0.02596520073711872,0.7710786461830139,neutral,0.17699092626571655
14,2019-06-28 03:00:00,That depends entirely on your outlook and goals.,0.017395243048667908,0.007951061241328716,0.9746537804603577,neutral,0.009444181807339191
15,2019-06-28 03:00:00,The company brought in a hefty $3.3 billion in free cash flow over the past year.,0.9343529939651489,0.016696928068995476,0.04895009472966194,positive,0.9176560640335083
16,2019-06-28 03:00:00,Shares trade for 36 times that amount.,0.07436209917068481,0.01113484613597393,0.9145030975341797,neutral,0.06322725117206573
17,2019-06-28 03:00:00,That's not outrageously expensive -- but it's also far from cheap.,0.2003871500492096,0.06549081206321716,0.7341220378875732,neutral,0.13489633798599243
18,2019-06-28 03:00:00,An investment in Salesforce is an investment in a founder-led company that is leading the SaaS revolution.,0.1539476066827774,0.005224362947046757,0.840828001499176,neutral,0.14872324466705322
19,2019-06-28 03:00:00,And it hasn't been shy about strategic acquisitions -- including the recent all-stock purchase of Tableau -- to further this leading position.,0.8267343640327454,0.015832290053367615,0.1574333757162094,positive,0.8109020590782166
20,2019-06-28 03:00:00,"At the end of the day, if mergers prove fruitful and demand for software keeps growing, Salesforce provides broad exposure to this important industry.",0.37806254625320435,0.008456927724182606,0.6134805083274841,neutral,0.3696056306362152
21,2019-06-28 03:00:00,"Going for the gold

Reuben Gregg Brewer (Royal Gold): Ten investment companies added at least two million shares each of Royal Gold in the first quarter, including names like Apollo, Citi, Lazard, and Wells Fargo.",0.31574079394340515,0.008627546951174736,0.6756316423416138,neutral,0.30711326003074646
22,2019-06-28 03:00:00,Why would some of the smartest people on Wall Street be jumping aboard this precious metals streaming company?,0.08943995833396912,0.08667953312397003,0.8238804936408997,neutral,0.0027604252099990845
23,2019-06-28 03:00:00,"Gold, which makes up nearly 80% of the company's revenues, is considered a ""safe haven"" investment.",0.7403303384780884,0.013467271812260151,0.24620242416858673,positive,0.7268630862236023
24,2019-06-28 03:00:00,"When Wall Street is tanking, investors often buy gold to protect the value of their portfolios.",0.12522315979003906,0.056124430149793625,0.8186523914337158,neutral,0.06909872591495514
25,2019-06-28 03:00:00,"With the S&P 500 Index near all-time highs and the swift and dramatic market moves over the past year or so, it makes sense that smart investors are adding a little more diversification to their portfolios.",0.8033909797668457,0.014889654703438282,0.18171940743923187,positive,0.7885013222694397
26,2019-06-28 03:00:00,Gold has historically been a great choice for that.,0.37766513228416443,0.013807186856865883,0.608527660369873,neutral,0.3638579547405243
27,2019-06-28 03:00:00,And Royal Gold is a wonderful way to do it.,0.5222359299659729,0.011242690496146679,0.46652132272720337,positive,0.510993242263794
28,2019-06-28 03:00:00,"The company is a streamer, meaning that it provides cash to miners for the right to buy gold (and other metals) at reduced rates in the future.",0.3811231851577759,0.009431272745132446,0.6094455718994141,neutral,0.37169191241264343
29,2019-06-28 03:00:00,That allows it to avoid the complications of running a mine while at the same time providing it with contractually wide margins.,0.6628236770629883,0.01104463916271925,0.3261316418647766,positive,0.651779055595398
30,2019-06-28 03:00:00,"In that way, it's better than a miner, for which falling commodity prices can lead to material red ink, and better than gold itself, which lacks growth potential (an ounce of gold will always be an ounce of gold; miners and streamers can increase production).",0.7427221536636353,0.0247524231672287,0.23252542316913605,positive,0.7179697155952454
31,2019-06-28 03:00:00,"Now add in a roughly 1% yield backed by 18 years of annual dividend increases and modest debt levels, and the allure of Royal Gold today is easy to understand.",0.4320220649242401,0.009353727102279663,0.5586242079734802,neutral,0.42266833782196045
32,2019-06-28 03:00:00,"George Budwell (Harpoon Therapeutics): If you haven't heard of the clinical-stage biotech Harpoon Therapeutics, you probably aren't alone.",0.021036891266703606,0.02628403715789318,0.9526790976524353,neutral,-0.005247145891189575
33,2019-06-28 03:00:00,"The pre-revenue immunotherapy company, after all, completed its initial public offering (IPO) only last February, and its novel T-cell-engaging platform is still in the early stages of development.",0.2667039930820465,0.008715556934475899,0.7245804071426392,neutral,0.25798842310905457
34,2019-06-28 03:00:00,"However, Harpoon did manage to intrigue numerous top-flight investors during its recent IPO, with renowned biotech-oriented funds like the Baker Bros. Advisors gobbling up a significant amount of shares right from the jump.",0.8083577156066895,0.03934408724308014,0.152298241853714,positive,0.7690136432647705
35,2019-06-28 03:00:00,What does Harpoon offer early-bird investors?,0.04851080849766731,0.012836609035730362,0.9386526346206665,neutral,0.03567419946193695
36,2019-06-28 03:00:00,"The company's value proposition centers around its antibody-derived platform, TriTAC, designed to target and destroy tumors.",0.3019283711910248,0.007120165508240461,0.6909514665603638,neutral,0.29480820894241333
37,2019-06-28 03:00:00,"As things stand now, the company has two assets -- HPN424 for prostate cancer and HPN536 for ovarian cancer -- in early-stage human trials.",0.22695274651050568,0.010426822118461132,0.7626203894615173,neutral,0.21652592718601227
38,2019-06-28 03:00:00,The company plans on broadening its clinical portfolio by launching other early-stage trials for product candidates targeting multiple myeloma and small cell lung cancer soon.,0.8661938309669495,0.012173806317150593,0.12163238227367401,positive,0.8540199995040894
39,2019-06-28 03:00:00,Each of these four initial indications represents a multibillion-dollar commercial opportunity.,0.7220067381858826,0.01121770404279232,0.26677560806274414,positive,0.7107890248298645
40,2019-06-28 03:00:00,Should investors take Wall Street's lead on this developmental biotech?,0.32976245880126953,0.024613965302705765,0.6456235647201538,neutral,0.30514848232269287
41,2019-06-28 03:00:00,"Frankly, the answer is probably a ""no"" at this point.",0.09187434613704681,0.2595400810241699,0.6485855579376221,neutral,-0.1676657348871231
42,2019-06-28 03:00:00,"Early-stage cancer candidates have a dreadful track record in the clinic, making Harpoon an extremely risky play.",0.04043203592300415,0.9038617610931396,0.05570618063211441,negative,-0.8634297251701355
43,2019-06-28 03:00:00,"Moreover, most biotech IPOs have turned out to be exceedingly poor investments over the last five years -- even though a select few companies like Kite Pharma and Juno Therapeutics did make their early shareholders a tidy sum.",0.025966374203562737,0.9376220107078552,0.03641153499484062,negative,-0.9116556644439697
44,2019-06-28 03:00:00,"Put simply, Harpoon is probably best viewed as an intriguing watch list candidate at this juncture, despite Wall Street's early enthusiasm.",0.4132422208786011,0.05160048231482506,0.535157322883606,neutral,0.3616417348384857
45,2019-06-28 03:00:00,"10 stocks we like better than Salesforce.com

When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen.",0.12068876624107361,0.033474430441856384,0.8458368182182312,neutral,0.08721433579921722
46,2019-06-28 03:00:00,"After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has quadrupled the market.",0.8087436556816101,0.0373060368001461,0.15395022928714752,positive,0.7714376449584961
47,2019-06-28 03:00:00,"*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Salesforce.com wasn't one of them!",0.20034073293209076,0.016208069398999214,0.7834511995315552,neutral,0.1841326653957367
48,2019-06-28 03:00:00,That's right -- they think these 10 stocks are even better buys.,0.8146857619285583,0.02307075634598732,0.16224350035190582,positive,0.7916150093078613
49,2019-06-28 03:00:00,Brian Stoffel has no position in any of the stocks mentioned.,0.010457303375005722,0.05455100163817406,0.934991717338562,neutral,-0.044093698263168335
50,2019-06-28 03:00:00,George Budwell has no position in any of the stocks mentioned.,0.010064548812806606,0.04272441938519478,0.9472110271453857,neutral,-0.0326598696410656
51,2019-06-28 03:00:00,Reuben Gregg Brewer has no position in any of the stocks mentioned.,0.008390056900680065,0.026033494621515274,0.9655764698982239,neutral,-0.017643436789512634
52,2019-06-28 03:00:00,The Motley Fool owns shares of and recommends Salesforce.com.,0.02858699858188629,0.023867284879088402,0.9475457072257996,neutral,0.00471971370279789
53,2019-06-28 03:00:00,The Motley Fool recommends Tableau Software.,0.05811826512217522,0.036098770797252655,0.90578293800354,neutral,0.02201949432492256
54,2019-06-28 03:00:00,The Motley Fool has a disclosure policy.,0.016547108069062233,0.01730392687022686,0.9661489725112915,neutral,-0.0007568188011646271
